Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval

Objective Compared to traditional drugs, specialty drugs tend to be indicated for lower prevalence diseases. Our objective was to compare the potential population health benefits associated with specialty and traditional drugs in the year following product approval.